Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Akso Health Group ADR (AHG)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/23/2025: AHG (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -31.81% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 479.35M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.67 | 52 Weeks Range 0.74 - 1.98 | Updated Date 06/29/2025 |
52 Weeks Range 0.74 - 1.98 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.08 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -77.92% | Operating Margin (TTM) -7.8% |
Management Effectiveness
Return on Assets (TTM) -3.73% | Return on Equity (TTM) -6.41% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 395956654 | Price to Sales(TTM) 56.7 |
Enterprise Value 395956654 | Price to Sales(TTM) 56.7 | ||
Enterprise Value to Revenue 46.83 | Enterprise Value to EBITDA -0.39 | Shares Outstanding 396160992 | Shares Floating 714403226 |
Shares Outstanding 396160992 | Shares Floating 714403226 | ||
Percent Insiders - | Percent Institutions 0.07 |
Upturn AI SWOT
Akso Health Group ADR
Company Overview
History and Background
Akso Health Group ADR (NASDAQ: AHG) is a health solutions provider, involved in producing and distributing health and wellness products. Founded to address the growing demand for health products, the company aims to leverage technology to deliver healthcare solutions. The company's history involves expanding product lines and establishing its market presence.
Core Business Areas
- Online Retail: Focuses on selling health and wellness products directly to consumers through online platforms.
- Offline Retail: Involves distributing health products via brick-and-mortar stores.
- Technology Services: Leverages technology to deliver health solutions, potentially including telehealth or digital health platforms.
Leadership and Structure
Information on Akso Health Group ADR's leadership team and organizational structure is limited in publicly available resources. Generally, it includes a CEO, CFO, and various department heads responsible for different business functions.
Top Products and Market Share
Key Offerings
- Health and Wellness Products: Includes a range of health and wellness products such as dietary supplements, personal care items, and medical devices. Market share data is not readily available. Competitors include GNC, Walgreens, and CVS.
- Medical Devices: May include products like blood pressure monitors or other home health devices. Market share data is not readily available. Competitors include Omron, Medtronic, and Philips.
Market Dynamics
Industry Overview
The health and wellness industry is experiencing growth driven by increasing consumer awareness of health and preventive care, and an aging population. The market is competitive, with numerous companies offering various products and services.
Positioning
Akso Health Group ADR's positioning in the industry is challenging to determine precisely without detailed market share data. The company likely aims to differentiate itself through a combination of product offerings and distribution channels.
Total Addressable Market (TAM)
The global health and wellness market is estimated to be worth trillions of dollars. Akso Health Group ADR is positioned to capture a portion of this market through its product offerings and distribution strategies.
Upturn SWOT Analysis
Strengths
- Diverse product range
- Distribution network
- Online retail presence
- Technology solutions
Weaknesses
- Limited brand recognition
- Lack of Market Share Data
- Potential regulatory risks
- Limited information availability
Opportunities
- Expanding product lines
- Entering new markets
- Partnerships with other companies
- Leveraging digital health trends
Threats
- Intense competition
- Changing consumer preferences
- Economic downturns
- Regulatory changes
Competitors and Market Share
Key Competitors
- GNC (GNC)
- CVS Health (CVS)
- Walgreens Boots Alliance (WBA)
- Walmart (WMT)
Competitive Landscape
Akso Health Group ADR faces intense competition from established players with greater brand recognition and resources. Its success depends on differentiating its products and services and effectively targeting specific market segments.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends cannot be determined without access to historical financial data.
Future Projections: Future growth projections based on analyst estimates are not readily available.
Recent Initiatives: Recent strategic initiatives would include expansion into the new distribution channels, strategic partnerships with medical distributors and retail health providers, and the development of a new product line focused on sports health.
Summary
Akso Health Group ADR is a health solutions provider with a diverse product range and distribution network. The company faces stiff competition and needs to improve brand recognition. Opportunities exist through market expansion and strategic partnerships. Financial data is limited, making a comprehensive analysis difficult.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website (limited)
- SEC Filings (limited)
- Industry Reports (general)
- Third-Party Financial Data Providers (limited)
Disclaimers:
The information provided is based on limited publicly available data and may not be entirely accurate. Financial analysis requires access to the company's official financial statements. This analysis is for informational purposes only and does not constitute financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Akso Health Group ADR
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2006-12-28 | CEO & Chairwoman of the Board Ms. Yilin Wang | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 9 | Website https://www.ahgtop.com |
Full time employees 9 | Website https://www.ahgtop.com | ||
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscope. In addition, it is involved in the provision of health treatment services. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.